[309 Pages Report] The breast lesion localization market is expected to strengthen its hold on the global market at an average CAGR of 4.1% between 2022 and 2032. The market is valued at US$ 256 Mn in 2022 and is likely to reach US$ 382 Mn by 2032. Previously, the market was thriving at a slightly higher CAGR of 4.9% (2015-2021), ensuring a market size of US$ 244 Million in 2021.
“Rising cases of breast cancer led by increased government spending on the research and development of drugs and services to counter the disease are flourishing the breast lesbian localization market, enhancing the healthcare structure while spreading awareness about the early diagnosis.”
Monitoring and diagnosis of cancer gain a lot of market traction for the breast lesion localization market. The increased use of advanced healthcare tools and services is leading breast cancer detection easy and confined. With the help of breast lesion localization services, the processes of imaging, screening, and scanning become smooth and easy.
As the market grows in the regions where breast cancer is the most common cancer among a lot of regions, it is attributed to the growth of the breast lesion localization market.
| Attributes | Details |
|---|---|
| Breast Lesion Localization Market CAGR (2022-2032) | 4.1% |
| Breast Lesion Localization Market Value (2022) | US$ 256 Million |
| Breast Lesion localization Market Value (2032) | US$ 382 Million |
A global study on the Breast lesion localization market shows that the rising breast cancer cases in the region are the driving factor for the market, coupled with the growing awareness around the new technologies coming into the diagnostics and healthcare sector is increasing the sales of breast lesion localization services.
Breast cancer’s early detection and screening, and treatment, according to that diagnosis, have gained a good amount of traction in the breast lesion localization market. Breast cancer is the second leading cancer-related death in women worldwide. Integration of the latest diagnosis practices with cutting-edge healthcare also makes the screening process easy.
The chances of getting breast cancer increase with the growing age as a type of adult stem cell at the root cause of breast cancer. This directly affects the myoepithelial cells, which eventually line the breast’s milk-producing liminal cells and works as tumor suppressors.
American cancer society explains that one out of eight women gets breast cancer under 45 of age. Though the number differs for women who are older than 45 years of age, approximately 2 out of 3 women develop invasive breast cancer.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Breast lesion localization market analysis has focused on explaining how the advent of covid-19 has shaped various markets differently. It has adversely affected some markets, damaging the supply chains, nullifying the distribution channels, and pushing markets towards turmoil. However, it has also been beneficial for a set of markets, especially the healthcare and diagnostics market.
People have become more aware of their health and keep a check on their vitals and health conditions through multiple diagnosis processes. Breast cancer, being one of the most common cancers out there, needs breast lesion localization services. People diagnosed with breast cancer have higher chances of getting covid-19 as their immunity is already low.
Breast lesion localization involves early detection and screening of breast cancer so it can be cured as soon as possible. The lockdown and travel restrictions affected the market’s growth in the first quarter of the pandemic, but as soon as diagnostic services started functioning, the market came back on track with a healthy growth rate.
Other components of the market also grow parallel, like breast biopsy, shaping the trends of the breast lesion localization market. These fuels the sales of breast lesion localization services in new regions.
“Rising chronic diseases like breast cancer and multiple diagnosis methods including early detection and screening coupled with it being the most prevalent cancer are helping the breast lesion localization market gain traction”
The government initiatives are working in order to spread awareness around breast cancer, diagnosis, symptoms, surgeries, and stages that help people in fighting against breast cancer.
Government programs also promote multiple kinds of diagnosis, treatment, and screening processes that help doctors and patients understand the real-time situation, pushing the demand for breast lesion localization. Another factor that creates multiple opportunities for the market is the high capital investments of emerging economies like India and China in their healthcare sector.
These countries are currently upgrading or building their healthcare structure, spending huge amounts on the development of the infrastructure. Countries also run programs to welcome the companies that provide a direct supply chain to healthcare and diagnostics services.
The shortage of oncologists is limiting the sales of breast lesion localization systems that perform by skilled professionals. The localization of tumors, lymphedema, seroma and risk of healthy tissue excision are some of the processes that breast lesion localization has.
Other reasons that restrict the market’s growth are the FDA approvals and the uncertainty attached to it. Players that operate the breast lesion localization need to obtain nuclear regulatory clearance to get listed among the registered operators.
Principal Consultant
Breast lesion localization Market:
| Attributes | Breast lesion localization Market |
|---|---|
| CAGR (2022-2032) | 4.1% |
| Market Value (2026) | US$ 300.64 Billion |
| Growth Factor | Rising cases of breast cancer, demand for technologically advanced diagnosis processes are increasing the sales of breast lesion localization platforms. |
| Opportunity | The market creates opportunities for the diagnosis centres to use advanced technology that run on different checks and touchpoints, enhancing the accuracy. |
| Key Trends | Platforms like artificial intelligence, machine learning and Internet of things (IOT) integrating with the breast lesion localization platforms are creating tons of opportunities for market. |
Skin Cancer Diagnostics & Therapeutics Market:
| Attributes | Skin Cancer Diagnostics & Therapeutics Market |
|---|---|
| CAGR (2022-2032) | 10% |
| Market Value (2026) | US$ 10.7 Billion |
| Growth Factor | Pollution and direct exposition to the UV rays is leading to the rising number of skin cancer patients in the various parts of the countries, pushing the skin cancer diagnostics & therapeutics market upward. |
| Opportunity | New advanced versions and stages are a challenge that creates multiple opportunities for the skin cancer diagnostics & therapeutics market to experiment and diversify their approach. |
| Key Trends | To get into multiple layers of symptoms, followed by the first line protocol while integrating with Artificial intelligence and machine learning. |
Oncology Market:
| Attributes | Oncology Market |
|---|---|
| CAGR (2022-2032) | 8% |
| Market Value (2026) | US$ 360 Billion |
| Growth Factor | Rising awareness regarding cancer and availability of various oncology treatments and innovative diagnostic tools, fueling the demand for oncology analysts. |
| Opportunity | The market creates opportunities for the component markets like cancer diagnosis and therapeutic, helping them find their space in the market race. |
| Key Trends | The machine learning and internet of things (IOT) integrate with oncology tools to make it easy and accurate are flourishing the trends of oncology market. |
Global trends in breast lesion localization market are followed by the new technology integrating and making the monitoring and scanning process easy so that it can be treated with precision. The use of cutting-edge technology like artificial intelligence, integrated healthcare platforms, digital monitors have helped the healthcare and diagnosis sector to evolve and get set up in new regions.
The consumption of breast lesion localization is attributed to its better care and screening that help to give the best possible results. Operators work with new cutting-edge technology to make sure they don’t miss out on advanced cell movement phenomena, making breast lesion localization systems the platform that holds accuracy.
The breast lesion localization market is categorized by type and usage. These categories are further divided into small segments that expand their channels in multiple market spaces. These segments perform differently in multiple markets as they have a stronghold in multiple regions.
The type category is segmented into wire localization, radioisotope localization, magnetic localization, and electromagnetic localization, while the usage category is divided into breast biopsy and breast conservation (Lumpectomy).
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By usage, the breast biopsy segment is the largest segment and will hold the biggest portion of the market in the forecast period. The analysis shows that the breast biopsy segment is set to thrive at a CAGR of 3.5% in the forecast period, while previously, the segment was thriving at a slightly higher CAGR of 4.0%.
Breast lesion localization market analysis explains that the factors behind the growth of this segment are its easy removal and short time span, and lower post-surgery impacts than the lumpectomy. Also, the breast biopsy can be used to remove an abnormality within the breast, while lumpectomy (Partial mastectomy) can only be used to remove breast cancer. These factors flourish the demand for breast lesion localization market.
The breast lesion localization market is divided into regions; North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe. The biggest market is the United States, which is flourishing at a CAGR of 3.9% between 2022-2032.
The region is likely to hold a market revenue of US$ 136.3 Mn by the end of 2032. Increasing breast cancer cases coupled with advanced diagnosis options while upgrading the healthcare system and their integration with the latest technology like AI and IOT are fueling the growth in this region.
The UK is the highest growing market globally and will hold US$ 18.2 Mn by the end of 2032 as it thrives on a promising CAGR of 4.4% between 2022-2032. Other regions like Asia pacific also flourished, with developing countries like China booming at a CAGR of 3.6% and Japan growing at a CAGR of 3.8%, while their projected values are US$ 28 Mn and US$ 25.2 Mn, respectively.
| Regions | CAGR (2022-2032) |
|---|---|
| United States | 3.9% |
| United Kingdom | 4,4% |
| China | 3.6% |
| Japan | 3.8% |
| South Korea | 3.0% |
The competitive landscape of breast lesion localization is dynamic in nature and allows new competitors to thrive in the market and increase competitiveness. The companies in the market are a part of mergers and collaborations that result in increased distribution channels and market spaces. These companies focus on updating the price ranges, while making the platforms more patient friendly.
Recent Developments in the Breast Lesion Localization Market:
The breast lesion localization market is set to grow at a CAGR of 4.1% through 2032.
North America is the biggest region in breast lesion localization market that is flourishing at at a CAGR of 3.5 by 2032.
Breast Biopsy is the leading segment in the breast lesion localization market by usage, thriving at a CAGR of 3.5% through 2032.
United Kingdom has the highest growth potential in the breast lesion localization market, thriving at CAGRs of 3.5% through 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Breast Lesion Localization Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Protective Coatings Market (US$ Mn) 4.2. Breast Lesion Localization Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Protective Coatings Market Growth 4.5.3. Breast Lesion Localization Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Breast Lesion Localization Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Breast Lesion Localization Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Breast Lesion Localization Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032 8.3.1. Wire Localization 8.3.2. Radioisotope Localization 8.3.3. Magnetic Localization 8.3.4. Electromagnetic Localization 8.3.5. Other Localization Methods 8.4. Market Attractiveness Analysis By Type 9. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Usage 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Usage, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2022-2032 9.3.1. Breast Biopsy 9.3.2. Breast Conservation (Lumpectomy) 9.4. Market Attractiveness Analysis By Usage 10. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. U.S. 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By Type 11.4.3. By Usage 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Type 11.5.3. By Usage 12. Latin America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Type 12.4.3. By Usage 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type 12.5.3. By Usage 13. Europe Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. U.K. 13.4.1.4. Italy 13.4.1.5. Benelux 13.4.1.6. Nordic Countries 13.4.1.7. Rest of Europe 13.4.2. By Type 13.4.3. By Usage 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By Usage 14. Asia Pacific Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By Type 14.4.3. By Usage 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By Usage 15. Middle East and Africa Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By Type 15.4.3. By Usage 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By Usage 16. Key Countries Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Breast Lesion Localization Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.2.2.1. By Type 16.2.2.2. By Usage 16.3. Canada Breast Lesion Localization Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.3.2.1. By Type 16.3.2.2. By Usage 16.4. Mexico Breast Lesion Localization Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.4.2.1. By Type 16.4.2.2. By Usage 16.5. Brazil Breast Lesion Localization Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.5.2.1. By Type 16.5.2.2. By Usage 16.6. Germany Breast Lesion Localization Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.6.2.1. By Type 16.6.2.2. By Usage 16.7. France Breast Lesion Localization Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.7.2.1. By Type 16.7.2.2. By Usage 16.8. Italy Breast Lesion Localization Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.8.2.1. By Type 16.8.2.2. By Usage 16.9. BENELUX Breast Lesion Localization Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.9.2.1. By Type 16.9.2.2. By Usage 16.10. UK Breast Lesion Localization Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.10.2.1. By Type 16.10.2.2. By Usage 16.11. Nordic Countries Breast Lesion Localization Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.11.2.1. By Type 16.11.2.2. By Usage 16.12. China Breast Lesion Localization Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.12.2.1. By Type 16.12.2.2. By Usage 16.13. Japan Breast Lesion Localization Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.13.2.1. By Type 16.13.2.2. By Usage 16.14. South Korea Breast Lesion Localization Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.14.2.1. By Type 16.14.2.2. By Usage 16.15. GCC Countries Breast Lesion Localization Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.15.2.1. By Type 16.15.2.2. By Usage 16.16. South Africa Breast Lesion Localization Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.16.2.1. By Type 16.16.2.2. By Usage 16.17. Turkey Breast Lesion Localization Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 16.17.2.1. By Type 16.17.2.2. By Usage 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. Hologic, Inc. 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. Becton, Dickinson and Company 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Merit Medical Systems 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Leica Biosystems Nussloch GmbH 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. Argon Medical Devices 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. Laurane Medical LLC 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. Endomagnetics Ltd. 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 18.3.8. Intramedical Imaging, LLC 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Sales Footprint 18.3.8.4. Strategy Overview 18.3.9. Isoaid 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Sales Footprint 18.3.9.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Healthcare
June 2016
REP-GB-1241
September 2023
314 pages
Explore Healthcare Insights
View Reports
Breast Lesion Localization Market
